Therma Bright Inc V.THRM

NEWS...but not news...

[boubouna]

Finally!!...a little late regurgitation....let's see what it does...

[TheScientist01]

unfortunately dont think its going to do much today for 2 reasons. 1st being that the market already had a chance to react to the news for whole 2 days while Therma was just sleeping basically... not really sure what they were hoping to do tbh. and 2nd being today's friday.. Therma on the Frankfurt exchange is already down 16% at the time of me writing this (8:30am est).. what the hell Therma.

[moonball32]

A very stock NR, probably scrambled to put something out "officially" after the news was already out. The communications from this company are very lacking and does not bode well for investor confidence. Hey Thermadmin, get your shyt together and stay current with keeping investors upto date

[ClemFandango]

One of the more important sections in this release: In addition to selecting the manufacturing partner for Asia, the Company has also quickly pivoted during the clinical studies in Brazil to an easier, more accurate and less expensive version of AcuVid. Now the AcuVid COVID-19 Rapid Antigen Saliva Test Kit is a much simpler, easy-to-use kit that will simplify the process for medical professionals

[mooseslayer]

Therma Bright will be able to add FDA Emergency Authorization Use (FDA-EUA) and Health Canada (HC) approved kits once regulatory approvals are secured

[mooseslayer]

I emailed Rob yesterday and told them they need to get an update out because there is news out there without an official news release. Probably coincidence but  I'll take credit for it lol

[mooseslayer]

If all of Asia uses this twice a week we will sell a chirload of them. Being part of a rapid testing solution, like AcuVid™, can assist citizens around the world to pursue twice-weekly serial testing regiments, while awaiting vaccinations. We're honored to be a part of Therma Bright's solution

[mooseslayer]

In March 2021, FDA Guidance was provided to test developers who were seeking emergency use authorization (EUA) of certain tests that could be used for serial testing, which includes the AcuVid™ COVID-19 Rapid Antigen Saliva Test. Serial testing involves testing the same individual multiple times within a few days, and can increase chances of detecting asymptomatic infection that